Related Experiment Videos
Antisense strategies and therapeutic applications
1Department of Pharmaceutics and Pharmaceutical Chemistry, University of Utah, Salt Lake City, UT 84112, USA.
Summary
Antisense therapy uses specific molecules to block disease-causing protein synthesis. This approach, utilizing antisense oligonucleotides, antigene sequences, and ribozymes, shows promise for various conditions and is advancing to clinical trials.
Area of Science:
- Molecular Biology
- Pharmacology
- Genetics
Background:
- Antisense therapy offers a novel approach to disease treatment by targeting specific DNA or RNA sequences.
- This method aims to block the synthesis of cellular proteins responsible for various diseases with high specificity.
Purpose of the Study:
- To discuss the fundamental concepts of antisense therapy.
- To examine the potential applications and therapeutic strategies of antisense agents.
- To review the different classes and mechanisms of antisense agents.
Main Methods:
- Antisense agents, including antisense oligonucleotides, antigene sequences, and ribozymes, are described.
- Mechanisms of action involve hybridization to mRNA or DNA to inhibit transcription or translation.
- Delivery methods and chemical modifications to enhance stability and cell penetration are explored.
Main Results:
- Antisense agents are being investigated for viral infections (HIV, HBV, HSV, HPV), cancer, restenosis, rheumatoid arthritis, and allergic disorders.
- Preliminary in vitro and in vivo results are promising, with some agents progressing to clinical trials.
- Modifications to phosphodiester linkages and the use of carrier systems (liposomes, polymers, nanoparticles) improve nuclease resistance and cellular uptake.
Conclusions:
- Antisense therapeutic agents represent a significant advancement in targeted disease therapy.
- Further research into delivery systems and pharmacokinetics is crucial for clinical success.
- Antisense agents have the potential to become a key component of future medicinal regimens.